Home Drugmaker Lilly's 2016 forecast misses Street expectations
 

Keywords :   


Drugmaker Lilly's 2016 forecast misses Street expectations

2016-01-05 15:04:53| Biotech - Topix.net

The drugmaker says it expects adjusted earnings in the new year to range between $3.45 and $3.55 per share, excluding charges like deal integration costs. It predicts revenue of between $20.2 billion and $20.7 billion.

Tags: street expectations forecast misses

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Delayed implementation of EID eartag rule requested
More »